Screening

Disparities Remain in Prevalence of Cancer Screening Tests

Disparities Remain in Prevalence of Cancer Screening Tests

Disparities persist in recommended cancer screening tests among U.S. adults, particularly among the uninsured.

Combined Digital Screening Best for Detecting Breast Cancers

Combined Digital Screening Best for Detecting Breast Cancers

Digital mammography and tomosynthesis proved superior to digital mammography alone, according to a study.

CDC Reports Screening Drop in Breast, Cervical, and Prostate Cancers

CDC Reports Screening Drop in Breast, Cervical, and Prostate Cancers

By

CDC investigators found that from 2000 to 2015, screening for breast, cervical, and prostate cancers decreased significantly.

Mortality Rates for Lung Cancer Likely to Surpass Breast Cancer Among Women by 2030

Mortality Rates for Lung Cancer Likely to Surpass Breast Cancer Among Women by 2030

By

Screening practices and smoking habits are expected to have a significant impact on mortality rates for lung cancer and breast cancer among women in high-income countries.

Lung Cancer Screening: Effective Models for Selecting the Most Candidates at Highest Risk

Lung Cancer Screening: Effective Models for Selecting the Most Candidates at Highest Risk

By

Four of 9 lung cancer screening models were shown to effectively select the most appropriate candidates for low-dose CT lung cancer screening among US ever-smokers.

USPSTF Updates Guidelines for PSA-Based Screening for Prostate Cancer in Older Men

USPSTF Updates Guidelines for PSA-Based Screening for Prostate Cancer in Older Men

By

In updating its 2012 recommendations, the US Preventive Services Task Force changes its stance on PSA-based screening for prostate cancer in men older than 50. The new guidelines advocate for a patient-physician discussion of the benefits of testing vs the potential harms.

Lung Cancer Screening Program In Ambulatory Clinics May Improve Detection Rates

Lung Cancer Screening Program In Ambulatory Clinics May Improve Detection Rates

By

A study presented at the 2018 ONS Annual Congress explored the feasibility of an advanced practice nurse-led lung cancer screening program at ambulatory outpatient clinics.

USPSTF: Decision to Undergo PSA Screening Should Be Individual

USPSTF: Decision to Undergo PSA Screening Should Be Individual

The decision to undergo periodic PSA screening for prostate cancer should be an individual one for men aged 55 to 69 years, according to the recommendation statement.

What Prompts Indoor Tanners and Nontanners to Undergo Skin Cancer Screening?

What Prompts Indoor Tanners and Nontanners to Undergo Skin Cancer Screening?

By

Researchers sought to determine the factors that influenced a decision to undergo skin cancer screening among more than 30,000 adults who have ever used an indoor tanning device and nontanners.

Challenges of Shared Decision Making in Prostate Cancer Screening

Challenges of Shared Decision Making in Prostate Cancer Screening

By

A review of shared decision making with men about undergoing PSA testing revealed that although full SDM discussions are increasing, variations in whether these discussions occur and how much information is shared still exist.

PSA Screening Increases Prostate Cancer Detection, No Significant Difference in Mortality

PSA Screening Increases Prostate Cancer Detection, No Significant Difference in Mortality

By

Researchers conducted a randomized clinical study of men to determine the impact of PSA screening on prostate cancer detection and mortality.

Following False-Positive Results, Patients More Likely to Have Future Cancer Screenings

Following False-Positive Results, Patients More Likely to Have Future Cancer Screenings

The researchers found that the choice to undergo future screenings appeared to be influenced by previous false-positive results for both men and women.

Cancer Screening Follow-up: Enabling Timely Diagnosis, Treatment

Cancer Screening Follow-up: Enabling Timely Diagnosis, Treatment

By

A review of the literature on follow-up after positive screening results led researchers to a consensus opinion on timing of diagnostic tests for 4 cancers: breast, cervical, colorectal, and lung.

False-Positive Cancer Screening Results May Increase Likelihood of Future Screenings

False-Positive Cancer Screening Results May Increase Likelihood of Future Screenings

By

A logistic regression analysis determined the effect receiving a false-positive result had on future participation in cancer screenings.

Screening Colonoscopy Improves CRC-Related Mortality in Veterans

Screening Colonoscopy Improves CRC-Related Mortality in Veterans

By

Researchers conducted a case-control study to determine whether colonoscopy is associated with decreased CRC mortality in veterans and whether its effect differs by anatomical location of CRC.

Factoring in Breast Density Improves Long-Term Risk Models for Breast Cancer

Factoring in Breast Density Improves Long-Term Risk Models for Breast Cancer

By

A study using a cohort of women from Kaiser Permanente Washington evaluated the accuracy of risk assessment models for breast cancer that included classic risk factors with and without breast density as an additional factor during more than 10 years of follow-up.

Does Better Breast Imaging Lead to Improved Outcomes or Increased Overdiagnosis?

Does Better Breast Imaging Lead to Improved Outcomes or Increased Overdiagnosis?

By

Advances in breast imaging such as DBT offer better, clearer images of breast tissue that can identify even low-grade DCIS tumors. But will more sensitive imaging lead to improved outcomes or increased overtreatment?

CHEST Panel Updates Criteria for Low-Dose CT Screening for Lung Cancer

CHEST Panel Updates Criteria for Low-Dose CT Screening for Lung Cancer

By

The panel assembled and updated the above guidelines and recommendations regarding lung cancer screening and low-dose CT screening programs.

Accountable Care Organizations linked to modest increase in appropriate cancer screening

1. Enrollment in Medicare Shared Savings Program (MSSP) Accountable Care Organizations (ACO) was associated with a decrease in breast cancer screening, increase in colorectal cancer screening, and decreased prostate cancer screening, reflecting more appropriate utilization of screening tests. 2. Changes in breast and colon cancer screening were strongly influenced by participant age. Evidence Rating Level: []

Colorectal Cancer Screening Rate Increased by Digital Self-Ordering

Colorectal Cancer Screening Rate Increased by Digital Self-Ordering

Fifty-three percent of intervention participants used app to self-order a colorectal screening test.

USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women

USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women

By

An USPSTF updated recommendation statement for ovarian cancer screening recommends against screening for women who are asymptomatic and do not have high-risk hereditary cancer syndrome.

Breast Cancer Screening Recommendations Not Completely Reflective of Race, Age

Breast Cancer Screening Recommendations Not Completely Reflective of Race, Age

By

An analysis of SEER data sought to examine the appropriateness of age- and race-specific breast cancer screening recommendations for white vs nonwhite women in the United States.

Breast cancer screening using MRI versus mammography associated with more biopsies but lower cancer yield

1. In women both with and without personal history of breast cancer (PHBC), screening MRI was associated with higher biopsy rates compared to mammography. 2. Screening MRI was also associated with lower rates of ductal carcinoma in situ (DCIS) and invasive cancer findings when compared to mammography. Evidence Rating Level: 2 (Good) Study Rundown: Screening []

Lung Cancer Screening: Risk-Targeting Approach vs NLST Eligibility Criteria

Lung Cancer Screening: Risk-Targeting Approach vs NLST Eligibility Criteria

By

In a review of data from the NLST, researchers sought to determine if a risk-targeting approach would more efficiently select high-risk persons for lung cancer screening than the eligibility criteria defined by the NLST.

Lung Cancer Screening More Efficient for Those at Higher Risk

Lung Cancer Screening More Efficient for Those at Higher Risk

Initial screens were least effective and least efficient for veterans with lowest lung cancer risk, according to this study.

Novel Approach Can Improve Both Colorectal Cancer Screening Outcomes and Adherence

Novel Approach Can Improve Both Colorectal Cancer Screening Outcomes and Adherence

By

Study results presented at the 2018 Gastrointestinal Cancers Symposium demonstrated the sensitivity and specificity of the CMx biomimetic platform, a novel approach to detecting CRC and precancerous lesions that could improve screening rates.

Risk-based lung cancer screening may prevent more deaths than current guidelines

1. In terms of early lung cancer death per individual screened, targeting lung cancer mortality risk may improve lung cancer screening efficiency. 2. However, the increases in efficiency were attenuated when measured by life-years, quality-adjusted life-years (QALYs), and cost-effectiveness. Evidence Rating Level: 2 (Good)          Study Rundown: Current guidelines for lung cancer screening using low-dose computed []

Ovarian Cancer Screening Potentially Cost-Effective in the United States

Ovarian Cancer Screening Potentially Cost-Effective in the United States

Multimodal screening is more expensive, but reduces ovarian cancer mortality, researchers found.

Compound in Teas, Peas, Soybeans May Increases Prostate Cancer Risk

Compound in Teas, Peas, Soybeans May Increases Prostate Cancer Risk

By

An analysis of an intervention arm of the PLCO Cancer Screening Trial evaluated the risk of prostate cancer relative to dietary consumption of isoflavones, a dietary compound found in some plant foods.

Novel Predictive Model More Effectively Identifies Risk for Lung Cancer

Novel Predictive Model More Effectively Identifies Risk for Lung Cancer

By

PanCan study results demonstrate the effectiveness of a novel predictive model in identifying risk of lung cancer in patients who do not meet the screening criteria of other models, including those used in the NLST.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs